abstract |
The present invention provides novel substituted bicyclic compounds that can be used as inhibitors of extra-terminal domain BET protein function by binding to bromodomains. Pharmaceutical compositions comprising such compounds are useful in the prevention and treatment of diseases and conditions associated with bromodomain and extra terminal domain (BET) proteins. |